Literature DB >> 7240738

In vitro killing of S. mansoni schistosomula by lymphokine-activated mouse macrophages.

D T Bout, M Joseph, J R David, A R Capron.   

Abstract

Inflammatory macrophages from mice i.p. injected with FCS 24-hr before harvesting, activated by partly purified MAF from Con A-stimulated spleen cells, were shown to kill an average of 60.9% (SE +/- 5.3) of the parasites in cultures of Schistosoma mansoni schistosomula. On the contrary, resident macrophages were not cytotoxic under the same conditions. The degree of macrophage activation for the killing was dependent upon both lymphokine concentration and time of incubation in lymphokine. The capacity of macrophages to be activated to kill schistosomula as well as the schistosomulicidal activity of the lymphokine-activated macrophages were short-lived properties. The killing was strongly influenced by the effector-to-target ratio. The results are consistent with other data on the immune response in experimental infection and particularly the development of the delayed hypersensitivity. Therefore, among the immune mechanisms that participate in immunity to reinfection, cell-mediated immunity that involves inflammatory macrophages should no longer be restricted to microorganisms and protozoans and could be extended to multicellular parasites like schistosomes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240738

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  A role for CD4+ but not CD8+ T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro 11-3128-terminated infections.

Authors:  D A Vignali; P Crocker; Q D Bickle; S Cobbold; H Waldmann; M G Taylor
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

2.  Activated macrophages as effector cells of protective immunity to schistosomiasis.

Authors:  S L James
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

3.  Effects of inhibitors of tumoricidal activity upon schistosomulum killing by activated macrophages.

Authors:  S L James; J A Glaven
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

4.  Differences in sensitivity of Schistosoma mansoni schistosomula, Dirofilaria immitis microfilariae, and Nematospiroides dubius third-stage larvae to damage by the polyamine oxidase-polyamine system.

Authors:  A Ferrante; I Ljungstrom; C M Rzepczyk; D M Morgan
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

5.  Localization of antiglomerular basement membrane-binding polyclonal antibodies in rat lung and kidney using post-embedding immunogold electron microscopy.

Authors:  N S Fernando; N W Boyce; S R Holdsworth; T J Neale
Journal:  Br J Exp Pathol       Date:  1989-10

6.  Destruction of the multicellular parasite Schistosoma mansoni by T lymphocytes.

Authors:  J J Ellner; G R Olds; C W Lee; M E Kleinhenz; K L Edmonds
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

7.  Tumour necrosis factor-alpha augments the expression of Fc IgE receptor (Fc epsilon RII/CD23) on human monocytic cell lines and down-regulates interleukin-4-driven Fc epsilon RII expression on monocytes.

Authors:  A Gessl; M Willheim; H Agis; A Spittler; A Schedle; W Krugluger; O Förster; G Boltz-Nitulescu
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

8.  Granulocyte-macrophage colony-stimulating factor in the sera of Schistosoma japonicum-infected mice.

Authors:  M Owhashi; Y Nawa
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

9.  Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi.

Authors:  E Brummer; C J Morrison; D A Stevens
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

10.  Helper T cells induced by a purified 28-kilodalton antigen of Schistosoma mansoni protect rats against infection.

Authors:  C Auriault; J M Balloul; R J Pierce; M Damonneville; P Sondermeijer; A Capron
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.